Searched for
DRUG DESIGN ENGINE
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Fable 5: Anthropic's latest AI model could transform IT, but at a costAnthropic's Fable 5 AI model showcases advanced agentic coding, capable of autonomous complex task completion and outperforming benchmarks....
- Claude Fable 5 & Mythos 5: Key highlights from Anthropic’s latest launchAnthropic has launched Claude Fable 5, its most capable publicly available AI model, excelling in complex tasks and benchmarks. Alongside i...
- India’s quantum opportunity: Turning scale into strategic advantageIndia has a structural advantage in quantum computing. Its size inherently creates challenging optimisation issues, offering a practical te...
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- PM Narendra Modi and PM Giorgia Meloni outline Indo-Mediterranean vision to deepen India-Italy tiesIndia and Italy are shaping an Indo-Mediterranean partnership focused on trade, AI, defence, clean energy and connectivity, with Narendra M...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Amaravati still under construction, but Quantum Valley project already luring deep tech startups, scientistsAmaravati, a new city in Andhra Pradesh, is becoming a hub for quantum computing. A technology park called Quantum Valley is attracting sci...
- DeepMind CEO Demis Hassabis’ Isomorphic Labs raises $2.1 billion led by Thrive CapitalAI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...
- Google’s Isomorphic Labs to raise over $2 billion in new fundingAlphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Airbus C295 lands on Purvanchal Expressway as part of IAF emergency drillAirbus landing on highway: The exercise was organised to assess the expressway’s potential as an alternative runway during times of war or ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 36%Whether you are a trader or an investor, there is one thing to watch carefully in the coming days: Earnings. The reason why this is importa...
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Biocon rolls out two biosimilars in US marketBiocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...
Load More
